肝臓学と膵臓科学

Innovations in Diagnosis and Treatment of Hepatobiliary and Pancreatic Disorders

Abstract

Byung-Wan Bae

Hepatobiliary and pancreatic disorders encompass a range of diseases affecting the liver, bile ducts, gallbladder, and pancreas. These disorders pose significant challenges to healthcare professionals due to their complexity and potential for serious complications. This article explores the latest innovations in the diagnosis and treatment of hepatobiliary and pancreatic disorders, highlighting advancements in imaging techniques, biomarkers, minimally invasive procedures, and targeted therapies. Accurate and early diagnosis plays a crucial role in the management of hepatobiliary and pancreatic disorders. Recent innovations in imaging technologies have significantly improved diagnostic capabilities. Magnetic Resonance Imaging (MRI), particularly with the use of hepatobiliary contrast agents, allows for high-resolution imaging of liver and biliary structures, aiding in the detection of lesions, characterization of tumors, and evaluation of bile duct abnormalities. Additionally, Contrast-Enhanced Ultrasound (CEUS) has emerged as a valuable tool for assessing liver lesions, providing real-time imaging with excellent contrast resolution and the ability to assess vascularity.